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Original Article
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Anatomy, Temple University School of Medicine, Philadelphia, PA, USA
ABSTRACT The pacemaker of endochondral bone growth is cell division and hypertrophy of
chondrocytes. The developmental stages of chondrocytes, characterized by the expression of
collagen types II and X, are arranged in arrays across the growth zone. Mutations in collagen II and
X genes as well as the absence of their gene products lead to different, altered patterns of
chondrocyte stages which remain aligned across the growth plate (GP). Here we analyze GP of rats
bearing the mutation toothless (tl) which, apart from bone defects, develop a progressive, severe
chondrodystrophy during postnatal weeks 3 to 6. Mutant GP exhibited disorganized, non-aligned
chondrocytes and mineralized metaphyseal bone but without cartilage mineralization or cartilaginous
extensions into the metaphysis. Expression of mRNA coding for collagen types II (Col II) and X (Col
X) was examined in the tibial GP by in situ hybridization. Mutant rats at 2 weeks exhibited Col II RNA
expression and some hypertrophied chondrocytes (HC) but no Col X RNA was detected. By 3rd
week, HC had largely disappeared from the central part of the mutant GP and Col II RNA expression
was present but weak and in 2 separate bands. Peripherally the GP contained HC but without Col
X RNA expression. This abnormal pattern was exacerbated by the fourth week. Bone mineralized
but cartilage in the GP did not. These data suggest that the tl mutation involves a regulatory function
for chondrocyte maturation, including Col X RNA synthesis and mineralization, and that the GP
abnormalities are related to the Col X deficiency. The differences in patterning in the tl rat GP
compared to direct Col X mutations may be explained by compensatory effects.
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toothless mutation in the rat.
Introduction
The pacemaker of endochondral bone formation is cell division
and hypertrophy of chondrocytes in growth plates (Farnum and
Wilsman, 1989; Hunziker, 1994). It is the proliferation, vectorial
extracellular matrix production and hypertrophy of chondrocytes
together with mineralization of the longitudinally aligned matrix
components that maintain the alignment and relative proportion of
cell types during longitudinal bone growth (Vanky et al., 1998).
Furthermore, the mineralized cartilage columns derived from growth
plates provide the scaffolding onto which metaphyseal bone matrix
is secreted and mineralized by osteoblasts (Marks, 1998). In
growth plate cartilages collagen type II (Col II) is synthesized by
proliferating chondrocytes. When these cells differentiate into
hypertrophied chondrocytes deeper in the growth plate, type II
collagen synthesis ceases and type X collagen (Col X) begins to be
produced (Iyama et al., 1991; Schmid et al., 1991). Thus, Col II and
X are exclusively expressed in proliferating and hypertrophic
chondrocytes, respectively (Castagnola et al., 1986).
Osteopetrotic mutations are characterized by skeletal sclerosis
resulting from interceptions of the development and/or function of
bone-resorbing cells, osteoclasts (Popoff and Marks, 1995). In
specific mutations a variety of other cells/tissues may be affected.
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In the toothless (tl) mutation in the rat (Marks, 1977) a chondrod-
ystrophy (Seifert 1994; 1996) develops by the third postnatal week.
Injections of colony-stimulating factor-1 (CSF-1) improve the skel-
etal sclerosis (Marks et al., 1993, 1992) but are without any effect
on the chondrodystrophy (Odgren et al., 1999). This chondrodys-
trophy in tl rats affects the development of cartilage and bone cells
and endochondral ossification (Seifert, 1996). Specifically the
zone of proliferating chondrocytes increases with age and the
hypertrophic chondrocyte zone decreases, both effects beginning
and being most obvious in the central regions.
Given these abnormalities in chondrocyte differentiation in
growth plates of tl rats, we have compared postnatal gene expres-
sion for collagens type II and X, regional chondrocyte morphology
and cartilage mineralization in tibial growth plates from mutant and
normal rats. These data are expected to clarify the interdependent
contributions of cartilage and bone cells during skeletal develop-
ment.
Results
Figure 1 demonstrates the differences in organization and
composition of the proximal tibial epiphyseal plates and metaphy-
ses in normal rats and osteopetrotic littermates one month after
birth. The growth plate in normal rats (Fig. 1A) is well organized
throughout with linear progressions of proliferating and hypertro-
phied chondrocytes and a matrix that stains metachromatically
Fig. 1. Representative photomicrographs of the
proximal tibia from 4-week-old normal (A) and
toothless (B) rats differentially stained with tolui-
dine blue. The growth plate cartilage (purple) is to-
ward the top of each figure and zones of proliferating
(p) and hypertrophied (h) chondrocytes are indicated.
In normal rats the growth plate cartilage is linear and
of uniform thickness and cellular composition. The
lateral cortical bone (c) is thick and the metaphyseal
trabeculae (in area delineated by the vertical line) have
cores of calcified cartilage (purple stain in this area). A
marrow cavity (M) can be seen in the lower part of the
figure (1A). In osteopetrotic (toothless-tl) mutants (1B)
there are no marrow cavities, cortical bone (C) is thin
and the growth plate cartilage is irregular in both shape
and composition. Laterally, zones of proliferating (p)
and hypertrophied (h) chondrocytes are present but
centrally the growth plate is greatly thickened and
includes areas of cell degeneration (arrowheads) and
few hypertrophied chondrocytes. In the metaphysis,
a lateral area (1) has cores of mineralized cartilage but
the central region (2) has bone with few such cartilage
remnants and irregular dilated venous (V) sinuses.
Toluidine blue, X45.
Figs. 2 and 3. Representative photomi-
crographs of the proximal tibia from a
2-week-old normal rat (N-Fig. 2) and
its toothless (tl-Fig. 3) littermate
stained with toluidine blue (A) and
illustrating gene expression by in situ
hybridization for collagens type II (B)
and X (C) in adjacent sections. Notice
that there is no mRNA expression for
collagen type X in tl rats (Fig. 3C). X40.
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dark blue in this figure. The metaphysis is of uniform
thickness and its bone is formed on scaffolds of
calcified cartilage, producing trabeculae with cores
of metachromatic cartilage matrix. A well developed
marrow cavity can be seen toward the center of the
tibia and it and the metaphysis are supported later-
ally by a thick cortex of bone. In tl mutants (Fig. 1B)
the growth plate is irregular in both composition and
thickness. Proliferating chondrocytes can be seen
throughout the growth plate but columns of hypertro-
phied cells are present only peripherally. Centrally
the growth plate has local thickenings which include
areas of cell degeneration without metachromatic
cartilage matrix. The metaphysis reflects these mani-
festations in the growth plate. Laterally the bony
trabeculae have cores of cartilage but centrally the
typical metachromatic staining of cartilage matrix is
absent. Instead, new bone forms here without a
preexisting cartilage scaffold and vascular sinuses
are prominent. There is no clearly delineated marrow
cavity and cortical bone in mutants is thinner than in
normal littermates.
Given the obvious distortions of form and compo-
sition in the growth plates and metaphyses in 4-
week-old mutants, we evaluated chondrocyte func-
tion at earlier ages using probes for collagens II and
X which are normally produced by growth plate
chondrocytes in different phases of their differentia-
tion. The expression of Col II and Col X in the
proximal tibial growth plate of 2-week-old normal rats
is shown in Figure 2. In these rapidly growing bones,
Col II RNA is expressed by proliferating chondrocytes
of the growth plate (Fig. 2A,B) and Col X RNA is
expressed by the hypertrophied chondrocytes (Fig.
2A,C). In 2-week-old tl rats (Fig. 3) Col II RNA is
expressed by proliferating chondrocytes (Fig. 3A,B)
but less intensely than in normal rats. Col X RNA is
not expressed by chondrocytes in the mutant skel-
eton (Fig. 3C), even though hypertrophied
chondrocytes can be identified in the mutant growth
we found in 2-week-old animals (Figs. 4C and 5C). Col II RNA
expression in normal 3-week-old rats (Fig. 6) was compact, con-
fined to the zone of proliferating chondrocytes (Fig. 6A,B) and was
most intense in the younger proliferating cell population. In mutants
(Figs. 7 and 8), Col II expression differed in the lateral and central
regions of the proximal tibial growth plate. In the lateral growth plate
Col II expression was linear and confined to proliferating cells (Fig.
7A,B). Centrally, Col II expression spread throughout the growth
plate and was much less intense than its expression laterally in
mutants. At higher magnification (Fig. 8) one can clearly see the
lack of uniform expression of Col II in the central growth plate (Fig.
8B) where two bands of higher expression are separated by a
region of low expression (rt. side of Fig. 8B). Thus, instead of the
suppressed expression of Col II during the differentiation of prolif-
erating normal chondrocytes (Fig. 6B), mutant chondrocytes ex-
hibit cyclical expression for Col II in a thickened growth plate with
few hypertrophic cells (right sides of Fig. 8A and B).
Based on the reported relationship between Col X and mineral-
ization in cartilage (Iyama et al., 1991; Kirsch and Von der Mark,
1991; Schmid et al.,1991), we examined the extent of mineraliza-
plate (Fig. 3A).
The differential expression of Col II and X in normal and mutant
growth plates is shown at higher magnification in Figures 4 and 5,
respectively. Here one can see that in normal rats Col II RNA is
highly expressed by a band of young proliferating chondrocytes
(Fig. 4A,B). Nearer to the zone of hypertrophy expression for this
gene is reduced, and it is not detected in hypertrophied chondrocytes
(Fig. 4B). In contrast, Col X RNA in normal rats is expressed
exclusively by hypertrophied chondrocytes (Fig. 4A,C), and this
expression ends abruptly at the chondro-osseous junction where
the growth plate abuts the proximal tibial metaphysis. In 2-week-
old tl rats (Fig. 5) Col II is expressed by proliferating chondrocytes
(Fig. 5A,B) but lacks the intense band of expression seen in the
young proliferating cells in normal littermates (Fig. 4B). There is no
expression of Col X RNA by mutant chondrocytes (Fig. 4C) even
though this section contains hypertrophied chondrocytes (Fig. 4A).
Next we evaluated gene expression for these two collagens in
the proximal tibial growth plates of 3-week-old animals. Expression
of Col X RNA was not detectable in mutant growth plates (data not
shown). Thus, the results at this age for Col X were identical to what
Figs. 4 and 5. Representative photomicrographs of the lateral part of proximal tibial
growth plate from a 2-week-old normal rat (N-Fig. 4) and a toothless rat (tl-Fig. 5)
at higher magnification than shown in the previous figures. Sections are stained with
toluidine blue (A) or incubated with probes to show by in situ hybridization expression of
mRNA for collagens II (II-B) and X (X-C) in adjacent sections. Notice that in normal rats (Fig.
4) cells in the zone of proliferating (p) chondrocytes express type II collagen (B) and those
in the zone of hypertrophy (h) express type X (C). In tl rats (Fig. 5), the expression pattern
for type II collagen is normal but the hypertrophied (h) chondrocytes do not express type
X collagen. X95.
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tion in growth plates of mutants (Fig. 9). Mutant cartilage exhibited
no mineralization and regions of cell degeneration in central areas
(Fig. 9A), where wide venous sinuses pressed directly onto the
unmineralized matrix. However, adjacent metaphyseal bone was
mineralized (Fig. 9B) in the mutant skeleton. These data demon-
strate a selective deficit of cartilage mineralization in the tl skeleton.
The regions of cell degeneration seen in the more mature (lower)
tibial growth plate of mutants (Figs. 1B and 9A) are preceded by
pyknotic cell clusters in younger parts of the growth plate (Fig. 10).
These degenerating cell groups appear early in the zone of
proliferation, suggesting that progeny of some cell divisions are
contracted and aborted soon after cell division is initiated in the
growth plate. Remnants of these degenerating cell clusters can be
seen more distally in the growth plate, together with intercellular
areas that stain weakly. Hypertrophied chondrocytes are small in
both number and size in the central regions of the mutant growth
plate (Fig. 10). In the normal growth plate cell death is only seen in
the terminal hypertrophied chondrocytes at the chondro-osseous
junction (Farnum and Wilsman, 1989; Hunziker, 1994).
In summary, these data demonstrate that in tl rats: 1)
type X collagen RNA is not expressed in the growth plate,
even though hypertrophic chondrocytes are present, al-
beit in reduced number and uneven distribution, 2) type II
collagen expression in growth plates is present but irregu-
lar; compact in the lateral part of the growth plate and
cyclical and diffuse centrally, 3) cartilage mineralization
fails but bone does mineralize, 4) centrally, cartilage does
not extend into the metaphysis (presumably because of
the failure of chondrocyte hypertrophy) and bone trabecu-
lae form here without a cartilage scaffold, 5) local areas of
pyknotic chondrocyte clusters early in the proliferative
zone are followed by regions of degenerating cells and
restricted chondrocyte hypertrophy deeper in the growth
plate.
Discussion
During long bone growth endochondral ossification
proceeds through consecutive steps of concurrent chon-
drocyte proliferation and production of Col II followed by
down-regulation of Col II, hypertrophy and production of
Col X. Recent data indicate that 80% of the growth in
murine bones is related to chondrocyte hypertrophy (Vanky
et al., 1998). Thus, it is not surprising that in tl rats where
few chondrocytes hypertrophy, long bone growth is re-
tarded (Seifert, 1996; Odgren et al., 1999). Mineralization
of cartilage normally begins in the early hypertrophic zone
and is mediated by matrix vesicles from these cells. The
regulation of chondrocyte maturation has recently been
shown to result from the local interactions of Indian
hedgehog (Ihh) and parathyroid hormone-related protein
(PTHrP) and its receptor (Kronenberg et al., 1997). The
expression of Ihh in maturing chondrocytes upregulates
PTHrP secretion from the perichondrium which, in turn,
acts as a paracrine suppressor of chondrocyte hypertro-
phy through PTHrP receptors on prehypertrophic cells
(Lee et al., 1996; Philbrick et al., 1996; Vortkamp et al.,
1996, 1998; Zou et al., 1997; Philbrick 1998). Hyper-
trophic chondrocytes also slow the maturation of their own
precursors in a negative-feedback loop and delay apoptosis
by upregulating Bcl-2 expression (Amling et al., 1997). Recently,
BMP-6 has been shown to be a positive regulator of avian chondro-
cyte differentiation (Grimsrud et al., 1999). These mechanisms
produce a growth plate with uniformly thick zones of chondrocyte
proliferation and hypertrophy (Fig. 1A). In the absence of PTHrP,
growth plates are thin and mineralization accelerated (Amizuka et
al., 1994; Karaplis et al., 1994; Weir et al., 1996). Maturation and
death of hypertrophic chondrocytes occurs, at least in part, by
signals from endothelial cells at the chondro-osseous junction
(Bittner et al., 1998) and involves the secretion of enzymes that
cross-link a variety of matrix molecules (Nurminskaya et al., 1998),
stabilizing the mineralized cartilaginous scaffold onto which osteo-
blasts deposit metaphyseal bone. In tl rats, proliferation of some
central chondrocytes is aborted, differentiation and hypertrophy of
the remainder are delayed, expression of Col II is irregularly
distributed and extended, and expression of Col X never occurs.
Mineralization of cartilage fails, there is no cartilaginous scaffolding
for bone formation in the central metaphysis and bone here forms
without a cartilaginous core (Fig. 1B). Laterally, the growth plate
Figs. 6,7 and 8. Representative photomicrographs of the proximal tibia from a 3-
week-old normal rat (N-Fig. 6) and a toothless littermate (tl-Figs. 7 and 8). Sections
in panel A are stained with toluidine blue and those in panel B show the expression of
type II (11) collagen mRNA in adjacent sections by in situ hybridization. In normal rats
(Fig. 6) collagen II expression (B) is linear and confined to the zone of proliferating (p)
chondrocytes. In toothless rats, the growth plate remains irregular in thickness with
hypertrophied chondrocytes (h) concentrated at the periphery and absent from most
central areas (Fig. 7A). Gene expression for type II collagen (Figs. 7B and 8B) is restricted
to proliferating (p) chondrocytes laterally but expressed by some cells in early hypertro-
phy centrally (Fig. 8B). X85 in Figures 6 and 8; X 40 in Figure 7.
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distortions are not as spectacular presumably be-
cause of adjacent periosteal collar influences on
chondrocyte differentiation (Bianco et al., 1998;
Long and Linsenmayer, 1998). Nevertheless, Col X
expression also fails in this region of the mutant
growth plate. It has recently been shown (Zerega et
al., 1999) that the addition of PTHrP to cultures of
hypertrophied avian chondrocytes suppresses both
expression of Col X and mineralization by these
cells. Given the perichondrial location of PTHrP
secreting cells in growing long bones (Zou et al.,
1997), the failure of Col X expression and mineral-
ization of cartilage by hypertrophied chondrocytes
in the lateral areas of the growth plate of tl rats could
be due to overexpression of PTHrP by adjacent
perichondrial cells. Explaining the pathology of cen-
tral areas of the tl growth plate (Fig. 1B) is more
difficult and may involve abnormalities in the PTHrP-
Ihh axis, BMP-6 and its receptor or Bcl-2 expres-
sion. Thus, expression of these genes needs to be
evaluated systematically in the tl growth plate during
development to understand the mechanisms for
regional differences in chondrocyte maturation. Fur-
thermore, a comprehensive analysis of the mecha-
nisms of the premature cell death and loss of
chondrocytes in the mutant growth plate is war-
ranted.
Type X collagen is a short, non-fibrillar collagen
synthesized by hypertrophic chondrocytes before
mineralization and vascular invasion of the growth
plate (Iyama et al., 1991; Kirsch and Von der Mark,
1991; Reichenberger et al., 1991; Schmid et al.,
1991; Claassen and Kirsch, 1994). Its appearance
only after chondrocyte hypertrophy, together with its
express Col X is associated with a failure of mineralization and
irregular, thick growth plates.
The chondrodystrophy that is characteristic of the tl mutation
(Seifert, 1994, 1996) appears to result from central regional de-
rangements in chondrocyte patterning (proliferation and hypertro-
phy) and gene expression. Hypertrophic chondrocytes occur in
reduced numbers and in skewed distributions in tibial growth
plates, and fail to express Col X RNA. Col II RNA is present, not in
well-aligned layers of cells, but rather concentrated to lateral parts
of the tibia. These derangements could be caused by deficiencies
in the cartilage matrix, which affect cartilage mineralization and
intercept recognition or adhesion by different cells. Osteoblasts do
not populate cartilage scaffolds in the metaphysis of tl rats, and
bone trabeculae are formed without a cartilage scaffold. Also in
cartilage itself, local clusters of pyknotic chondrocytes appear early
in the proliferative zone, followed by regions of cell degeneration
and restricted hypertrophy toward the metaphysis. Both phenom-
ena may be mediated by the failure of vascularization, i.e. the
interaction of endothelial cells with cartilage matrix. This failure
could interfere with both the supply of nutrients and oxygen to
chondrocytes and with the entrance of osteoblast precursors. The
end result of these abnormalities in chondrocyte development is
the retardation of long bone growth, presumably mediated by the
failure of the growth plate to provide a mineralized cartilage surface
for the orderly attraction and differentiation of bone cell precursors
expression by chondrocytes in sites of mineralization at tendon
insertions (Niyibizi et al., 1996) and osteoarthritic transformation of
articular cartilage (Hoyland et al., 1991), have suggested a role for
type X collagen in mineralization. Type X collagen is found in two
forms in the extracellular matrix (Schmid and Linsenmayer, 1990):
as fine filaments adjacent to hypertrophic chondrocytes and in the
interstitial matrix in association with type II collagen (Chen et al.,
1992). Degradation of Col X occurs in the metaphysis by the
combined actions of degradative enzymes present in osteoclasts
(Sires et al., 1995; Vu et al., 1998).
Mutations in the Col X gene lead to metaphyseal chondroplasias
characterized by thin growth plates and metaphyses (Jacenko et
al., 1993; Olsen, 1995; Pokharel et al., 1995) quite opposite the
skeletal manifestations in tl rats (Seifert, 1994, 1996). Cloning of
the mouse gene (Apte et al., 1992; Elima et al., 1993) made Col X-
deficient mice available for analysis. Early studies revealed (Rosati
et al., 1994) no gross abnormalities in bone growth or development
in these mice, but subsequent analyses (Kwan et al., 1997)
showed reductions in resting chondrocytes and articular cartilage
thickness and a shift of matrix vesicles and proteoglycans from the
zone of hypertrophy to earlier stages in chondrocyte differentiation.
Furthermore, Col X null mice show no abnormalities in chondrocyte
morphology or differentiation patterns including premature apoptosis
(Kwan et al., 1997). These subtle deficiencies in Col X deficient
mice contrast with the manifestations in tl rats where failure to
teristic of hypertrophic chondrocytes (arrowheads). Areas of necrosis, acellularity and loss of
metachromasia (asterisk) indicate focal, interstitial loss of cartilage cells and matrix. This is
presumably due to premature chondrocyte death which releases enzymes that enlarge
lacunae and degrade the proteoglycans responsible for the metachromatic staining of these
areas with toluidine blue. The cells representing the hypertrophic cell zone show a mixed
expression of morphologies and here cartilage matrix fails to mineralize (no black deposits of
silver ions from the Von Kossa reaction, which shows that bone (mt) does mineralize at the
bottom of this figure). Large, dilated metaphyseal vessels (v) irregularly invade this region.
Numerous osteoblasts (o) directly line unmineralized cartilage trabeculae or the metaphyseal
surface of the growth plate. (B) Osteoblasts deposit an osteoid matrix on the metaphyseal
surface of the growth plate or along unmineralized cartilage trabeculae which mineralizes to
form irregularly shaped trabeculae (mt). Toluidine blue/von Kossa. X125.
Fig. 9. Photomicrographs of the lower
central region of the proximal tibial
growth plate in 3-week-old tl rats. (A)
The distinctive maturational morphologies
of chondrocytes and their organization into
well-defined proliferative and hypertrophic
cell zones, present in normal animals (Figs.
4 and 6), are lacking in mutant rats. Cells in
the lower proliferative zone are less nu-
merous and appear as dispersed single,
enlarged cells with features more charac-
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(Marks, 1997). The cortices of all growing bones are initially thin
and they thicken during remodeling of the primary bone (Marks,
1998). This remodeling is blocked in the tl rat, due to depressed
bone resorption. Thus, thin cortices and growth retardation coexist
in this mutation due to abnormalities in bone resorption and
chondrocyte differentiation, respectively.
In summary, we have shown that in the tl mutation in the rat
hypertrophic chondrocytes are few in number, fail to express Col X
and cartilage does not mineralize. Furthermore, premature degen-
eration of some early proliferating chondrocyte clusters produces a
distorted growth plate in whose central regions chondrocytes con-
tinue to irregularly produce Col II mRNA but not cartilage cores for
metaphyseal bone. The chondrometaphyseal dysplasia that results
compromises skeletal growth and disrupts the currently unspecified
interdependent messages from both cartilage and metaphyseal
bone that produce the predictable, coordinated differentiation of
cartilage and bone cells that mediate longitudinal bone growth. Given
the abnormalities in cartilage (Seifert, 1994, 1996) and bone (Seifert
et al., 1988; Shalhoub et al., 1991; Sundquist et al., 1995; Wisner-
Lynch et al., 1995; Marks, 1997; Watanabe et al., 1997, 1998) cells
and in the skeletal vasculature (Aharinejad et al., 1995), this mutation
will be a valuable model for exploring the roles of these cells and
tissues in the development and maintenance of the skeleton. How a
single, autosomal recessive mutation in tl rats produces such a
unique constellation of effects including compensatory adjustments
remains to be established.
Materials and Methods
All the experiments performed in this study were approved by the
Institutional Animal Care and Use Committee of the University of Massa-
chusetts Medical Center (UMMC). Animals were maintained and used at
the UMMC according to the recommendations in the Guide for the Care and
Use of Laboratory Animals, prepared by the Institute on Laboratory Animal
Resources, National Research Council (DHHS Publ. NIH 86-23, 1985).
Source of animals and tissue processing
Rats were obtained from our breeding colonies at the UMMC and
mutants (tl/tl) were identified radiographically at birth (Schneider et al.,
1979) by the failure of development of marrow cavities in long bones.
Normal homozygotes (+/+) and heterozygotes (tl/+) are distinguishable
only by breeding, and normal littermates included both these genotypes.
Rats of normal and mutant phenotypes were killed by cervical dislocation
at 2,3 and 4 weeks after birth. The proximal tibiae were quickly isolated,
cleaned of muscles, bisected in the sagittal plane and immersion fixed in
freshly prepared 4% paraformaldehyde in RNase-free phosphate-buffered
saline, pH 7.0, at 4oC for 24 h. Bisected tibiae including the proximal growth
plate were demineralized in 0.3M EDTA, pH7.0, at 4oC, dehydrated and
vacuum-embedded in paraffin. Serial sections were cut at 7 µm, floated on
RNase-free water and mounted on clean glass slides pretreated with
aminopropyl triethoxysilane (Sigma, St. Louis, MO). Blocks and glass-
mounted sections were stored at 4oC until used.
Tibiae were also removed and sectioned in the mid-sagittal plane. Under
magnification, parallel 1-mm thick parasagittal slices containing the proximal
growth plate cartilage and metaphysis were cut, fixed and processed
undecalcified according to the method of Hunziker and Hermann (1982)
(Hunziker, 1994) which optimally preserves chondrocytes in their fully
expanded state. Briefly, slices were fixed for 2 h in 2% glutaraldehyde in 0.05
M cacodylate buffer, pH 7.4, containing 0.7% ruthenium hexamine trichloride
(RHT; Polysciences, Inc., Warrington, PA, USA). Slices were then rinsed in
0.1 M cacodylate buffer and postfixed in 1% osmium tetroxide in 0.1 M
cacodylate buffer containing 0.7% RHT. The presence of RHT, a low
molecular weight cationic dye of high positive charge density, in the fixatives
causes precipitation of pericellular proteoglycans and maintains plasma
membrane bonds with the surrounding extralacunar matrix. This minimizes
extraction of proteoglycans and the artifactual shrinkage of chondrocytes that
accompany conventional aqueous fixation methods. Slices were dehydrated
in ethanol and embedded in epoxy resin. Semi-thin sections (1 µm) were cut
and stained for mineral by the von Kossa method (Seifert, 1996) and
counterstained in 0.5% toluidine blue in 1% sodium borate.
Probes for hybridization
Clones containing rat Col II and X mRNA sequences were selected from
a femur cDNA library as described, and inserts were sequenced (Wurtz et
al., 1998). Aligned sequences were deposited under the accession num-
bers AJ224879 and AJ131848, respectively, in the EMBL database.
RNA probes were synthesized in the presence of digoxygenin (DIG)-
modified UTP by an in vitro transcription kit (Boehringer Mannheim,
Mannheim, Germany) as directed by the manufacturer. Controls including
Fig. 10. A montage of the entire
thickness of the central region
of tibial growth plate from a 3-
week-old tl rat showing the rest-
ing (RZ), proliferative (PZ) and
hypertrophic (HCZ) cell zones.
Several cells within isogenous cell
clusters located in the upper pro-
liferative zone show evidence of
cell death (pycnotic nuclei, vacu-
olated cytoplasm) (arrowheads).
This premature cell death may
cause the reduction in cartilage
cellularity and the abnormal zonal
organization. Cell orientation is
disrupted in the HCZ and longitu-
dinal septae here fail to mineralize
(asterisk). The lack of organization
of these cells into orderly columns
possessing transverse septae
may interfere with normal vascu-
lar invasion. Toluidine blue/von
Kossa. X135.
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sense probes and the insert of pSPT19-Neo (Boehringer Mannheim) were
also transcribed. The oligonucleotides transcribed for Collagen αI (II) and
Collagen αI (X) were specific and showed no crossreactivity (Wurtz et al.,
1998; and unpublished data).
In situ hybridization
The sections obtained from sagitally sectioned tibiae were reacted with
the DIG-labeled riboprobes for Col II, Col X or control probes in an in situ
hybridization protocol developed at the Center for Oral Biology specifically
for analyzing gene expression in mineralized tissues. This method has
been described (Liao et al., 1998; Wurtz et al., 1998; Marks et al., 1999).
Briefly, deparaffinized sections were exposed to 0.2M HCl, proteinase K
and glycine, post fixed in 4% paraformaldehyde, reacted with triethanola-
mine and hybridized overnight at 42oC in a sealed humid chamber while
exposed to 0.5 ng DIG-UTP-labeled riboprobe/µL. High stringency washes
and RNase treatment preceded identification of specifically bound DIG-
labeled riboprobes by reacting with an alkaline phosphatase-coupled DIG
antibody (Boehringer Mannheim). Exposure times for development ranged
from 100 to 180 min depending upon the probe and the age of the animal.
Gene expression for Col II and X in the tibial growth plate was evaluated
in adjacent sections of the same block for each probe and every fifth section
was stained with toluidine blue to identify more precisely the cell popula-
tions expressing each gene. Sections from normal and mutant rats of the
same age were examined by in situ hybridization at the same time,
facilitating comparisons. At least 5 sections for each probe from at least
three animals of each age and genotype were analyzed to determine the
sites, times, intensity and patterns of gene expression for Col II and X in the
proximal epiphyseal plate. All control probes were negative.
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